Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis

Abstract Background Few data are available on COVID-19 outcomes among pregnant women in sub-Saharan Africa (SSA), where high-risk comorbidities are prevalent. We investigated the impact of pregnancy on SARS-CoV-2 infection and of SARS-CoV-2 infection on pregnancy to generate evidence for health policy and clinical practice. Methods We conducted a 6-country retrospective cohort study among hospitalized women of childbearing age between 1 March 2020 and 31 March 2021. Exposures were (1) pregnancy and (2) a positive SARS-CoV-2 RT-PCR test. The primary outcome for both analyses was intensive care unit (ICU) admission. Secondary outcomes included supplemental oxygen requirement, mechanical ventilation, adverse birth outcomes, and in-hospital mortality. We used log-binomial regression to estimate the effect between pregnancy and SARS-CoV-2 infection. Factors associated with mortality were evaluated using competing-risk proportional subdistribution hazards models. Results Our analyses included 1315 hospitalized women: 510 pregnant women with SARS-CoV-2, 403 nonpregnant women with SARS-CoV-2, and 402 pregnant women without SARS-CoV-2 infection. Among women with SARS-CoV-2 infection, pregnancy was associated with increased risk for ICU admission (adjusted risk ratio [aRR]: 2.38; 95% CI: 1.42–4.01), oxygen supplementation (aRR: 1.86; 95% CI: 1.44–2.42), and hazard of in-hospital death (adjusted sub-hazard ratio [aSHR]: 2.00; 95% CI: 1.08–3.70). Among pregnant women, SARS-CoV-2 infection increased the risk of ICU admission (aRR: 2.0; 95% CI: 1.20–3.35), oxygen supplementation (aRR: 1.57; 95% CI: 1.17–2.11), and hazard of in-hospital death (aSHR: 5.03; 95% CI: 1.79–14.13). Conclusions Among hospitalized women in SSA, both SARS-CoV-2 infection and pregnancy independently increased risks of ICU admission, oxygen supplementation, and death. These data support international recommendations to prioritize COVID-19 vaccination among pregnant women.

[1]  Christopher A Gravel,et al.  Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes. , 2022, JAMA.

[2]  A. Papageorghiou,et al.  Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection , 2021, JAMA pediatrics.

[3]  C. Cluver,et al.  Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV. , 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[4]  G. Girardi,et al.  Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating. , 2021, Obstetrics and gynecology.

[5]  J. Nachega,et al.  Opportunities and Challenges in North-South and South-South Global Health Collaborations During the COVID-19 Pandemic: The AFREhealth-CUGH Experience (as Reported at the CUGH 2021 Satellite Meeting) , 2021, Annals of global health.

[6]  S. Fawcus,et al.  Maternal characteristics and pregnancy outcomes of hospitalized pregnant women with SARS‐CoV‐2 infection in South Africa: An International Network of Obstetric Survey Systems‐based cohort study , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  A. Wilcox,et al.  Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020–21 , 2021, Research square.

[8]  R. Karron,et al.  Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review , 2021, Vaccine.

[9]  J. Nkengasong,et al.  COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead , 2021, Immunity.

[10]  C. Olson,et al.  Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons , 2021, The New England journal of medicine.

[11]  J. Stanford,et al.  The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis , 2021, BMC Pregnancy and Childbirth.

[12]  A. Palanisamy,et al.  The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United States , 2021, Anesthesia and analgesia.

[13]  L. Chauke,et al.  Maternal mortality from COVID 19 among South African pregnant women , 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[14]  Shiliang Liu,et al.  The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis , 2021, Canadian Medical Association Journal.

[15]  T. R. D. de Wit,et al.  Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia , 2021, International Journal of Infectious Diseases.

[16]  N. Sam-Agudu,et al.  COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa , 2021, Globalization and Health.

[17]  M. Shrotri,et al.  An interactive website tracking COVID-19 vaccine development , 2021, The Lancet Global Health.

[18]  N. Sewankambo,et al.  The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  D. Bianchi,et al.  Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines. , 2021, JAMA.

[20]  P. Brocklehurst,et al.  The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS) , 2021, medRxiv.

[21]  J. Nachega,et al.  Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration , 2020, The American journal of tropical medicine and hygiene.

[22]  L. Poon,et al.  Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: analysis of the Mexican National Surveillance Program , 2020, American Journal of Obstetrics and Gynecology.

[23]  L. Pomar,et al.  Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[24]  E. Olsen,et al.  Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[25]  J. Nachega,et al.  Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo , 2020, The American journal of tropical medicine and hygiene.

[26]  M. Guida,et al.  Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19 , 2020, Journal of perinatal medicine.

[27]  N. Sam-Agudu,et al.  Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa , 2020, Pediatric Research.

[28]  L. Mofenson,et al.  Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.

[29]  A. Benachi,et al.  Are clinical outcomes worse for pregnant women at ≥20 weeks’ gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching , 2020, American Journal of Obstetrics and Gynecology.

[30]  Jessica K De Freitas,et al.  Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

[31]  A. Spanevello,et al.  Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases , 2020, European Respiratory Journal.

[32]  J. Simpson,et al.  Malaria and immunity during pregnancy and postpartum: a tale of two species , 2015, Parasitology.

[33]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.

[34]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[35]  C. Dolea,et al.  World Health Organization , 1949, International Organization.